Treatments for tuberculosis and non‐tuberculous mycobacterial lung infections: dual-targeted rifamycin‐AAP conjugates
Principal Investigator: Richard H. Ebright
Affiliation: Professor Professor of Chemistry and Chemical Biology, School of Arts and Sciences
Award Amount: $200,000
Research Sponsor: Rutgers HealthAdvance, Office for Research